{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:00:53Z","timestamp":1778878853487,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603018"],"award-info":[{"award-number":["81603018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical and Translational Science Foundation","award":["2017LY03"],"award-info":[{"award-number":["2017LY03"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.cca.2018.03.040","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T11:47:22Z","timestamp":1523015242000},"page":"215-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Human epididymis protein 4 in endometrial cancer: A meta-analysis"],"prefix":"10.1016","volume":"482","author":[{"given":"Li-man","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-xuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2018.03.040_bb0005","first-page":"29","article-title":"Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis","volume":"e20","author":"Miyamoto","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.cca.2018.03.040_bb0010","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.12659\/MSM.890478","article-title":"Surgical management of early endometrial cancer: an update and proposal of a therapeutic algorithm","volume":"20","author":"Falcone","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.cca.2018.03.040_bb0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","article-title":"Risk factors for young premenopausal women with endometrial cancer","volume":"105","author":"Soliman","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.cca.2018.03.040_bb0020","doi-asserted-by":"crossref","first-page":"115360","DOI":"10.18632\/oncotarget.23264","article-title":"Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2018.03.040_bb0025","first-page":"1","article-title":"The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis","volume":"23","author":"Yucel","year":"2018","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.cca.2018.03.040_bb0030","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000444321","article-title":"Assessment of cervicovaginal cancer antigen 125 levels: a preliminary study for endometrial cancer screening","volume":"81","author":"Calis","year":"2016","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.cca.2018.03.040_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejogrb.2012.05.038","article-title":"Preoperative serum CA 125 level in the prediction of the stage of disease in endometrial carcinoma","volume":"164","author":"Yildiz","year":"2012","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.cca.2018.03.040_bb0040","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ijc.26433","article-title":"The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer","volume":"131","author":"Nicklin","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cca.2018.03.040_bb0045","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.2214\/AJR.14.13746","article-title":"Preoperative pelvic MRI and serum cancer antigen-125: selecting women with grade 1 endometrial cancer for lymphadenectomy","volume":"205","author":"Sadowski","year":"2015","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.cca.2018.03.040_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-405211-6.00001-2","article-title":"Human epididymis protein 4 in cancer diagnostics: a promising and reliable tumor marker","volume":"59","author":"Speeckaert","year":"2013","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.cca.2018.03.040_bb0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbrc.2012.02.008","article-title":"Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility","volume":"419","author":"Lu","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2018.03.040_bb0060","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cca.2018.03.040_bb0065","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2011.109","article-title":"Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients","volume":"104","author":"Bignotti","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cca.2018.03.040_bb0070","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5603\/GP.2016.0088","article-title":"The role of HE4 and CA125 in differentiation between malignant and non-malignant endometrial pathologies","volume":"87","author":"Abdalla","year":"2016","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.cca.2018.03.040_bb0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus","volume":"110","author":"Moore","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2018.03.040_bb0080","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1515\/cclm-2011-0757","article-title":"Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome","volume":"50","author":"Zanotti","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2018.03.040_bb0085","first-page":"125","article-title":"Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma","volume":"47","author":"Zhang","year":"2012","journal-title":"Zhonghua fu chan ke za zhi"},{"key":"10.1016\/j.cca.2018.03.040_bb0090","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13277-012-0583-0","article-title":"The role of novel biomarker HE4 in endometrial cancer: a case control prospective study","volume":"34","author":"Angioli","year":"2013","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2018.03.040_bb0095","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1007\/s13277-013-0814-z","article-title":"The diagnostic role of human epididymis protein 4 and serum amyloid-a in early-stage endometrial cancer patients","volume":"34","author":"Omer","year":"2013","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2018.03.040_bb0100","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/aogs.12235","article-title":"HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)","volume":"92","author":"Antonsen","year":"2013","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.cca.2018.03.040_bb0105","first-page":"327","article-title":"CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management","volume":"34","author":"Presl","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cca.2018.03.040_bb0110","first-page":"1239","article-title":"Value of detection of serum human epididymis secretory protein 4 and carbohydrate antigen 125 in diagnosis of early endometrial cancer of different pathological subtypes","volume":"8","author":"Liu","year":"2015","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.cca.2018.03.040_bb0115","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2015.11.020","article-title":"Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer","volume":"140","author":"Kemik","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2018.03.040_bb0120","doi-asserted-by":"crossref","first-page":"260","DOI":"10.17772\/gp\/62356","article-title":"The role of HE4 in differentiating benign and malignant endometrial pathology","volume":"87","author":"Gasiorowska","year":"2016","journal-title":"Ginekol. Pol."},{"key":"10.1016\/j.cca.2018.03.040_bb0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/01443615.2016.1174199","article-title":"The role of human epididymis secretory protein E4 in patients with endometrial cancer and premalignant endometrial lesions","volume":"37","author":"Yilmaz","year":"2017","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.cca.2018.03.040_bb0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5152\/eurasianjmed.2016.0259","article-title":"Endometrial and ovarian cancer with MR imaging importance of serum HE4 and CA 125 levels in the extent of disease at evaluation","volume":"48","author":"Yilmaz","year":"2016","journal-title":"Eurasian J. Med."},{"key":"10.1016\/j.cca.2018.03.040_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22223","article-title":"The clinical significance of DJ-1 and HE4 in patients with endometrial cancer","volume":"32","author":"Benati","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.cca.2018.03.040_bb0140","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2147\/OTT.S136750","article-title":"Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients","volume":"10","author":"Cymbaluk-Ploska","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.cca.2018.03.040_bb0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2017.07.130","article-title":"Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer","volume":"147","author":"Knific","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.cca.2018.03.040_bb0150","first-page":"XC01","article-title":"Diagnostic performance of serum human epididymis protein 4 in endometrial carcinoma: a pilot study","volume":"11","author":"Dewan","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.cca.2018.03.040_bb0155","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.12669\/pjms.334.12755","article-title":"Value of HE4 combined with cancer antigen 125 in the diagnosis of endometrial cancer","volume":"33","author":"Dong","year":"2017","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.cca.2018.03.040_bb0160","first-page":"391","article-title":"Meta-analysis of serum gastrin-releasing peptide precursor as a biomarker for diagnosis of small cell lung cancer","volume":"18","author":"Lv Sh","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.cca.2018.03.040_bb0165","first-page":"3725","article-title":"The diagnostic value of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase measurement in the sera of patients with endometrial cancer","volume":"33","author":"Orywal","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cca.2018.03.040_bb0170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7754\/Clin.Lab.2013.130312","article-title":"Diagnostic accuracy of Golgi protein 73 in primary hepatic carcinoma using ELISA: a systematic review and meta-analysis","volume":"60","author":"Cao","year":"2014","journal-title":"Clin. Lab."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118301566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118301566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T17:24:30Z","timestamp":1534958670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898118301566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":34,"alternative-id":["S0009898118301566"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.03.040","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human epididymis protein 4 in endometrial cancer: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.03.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}